VARRONE, ANDREA
 Distribuzione geografica
Continente #
AS - Asia 1.212
NA - Nord America 840
EU - Europa 263
SA - Sud America 226
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 2.556
Nazione #
US - Stati Uniti d'America 815
SG - Singapore 559
CN - Cina 250
BR - Brasile 189
VN - Vietnam 126
HK - Hong Kong 109
FR - Francia 80
NL - Olanda 78
KR - Corea 55
IN - India 28
DE - Germania 24
JP - Giappone 23
IT - Italia 19
BD - Bangladesh 15
GB - Regno Unito 14
AR - Argentina 12
FI - Finlandia 10
MX - Messico 9
EC - Ecuador 8
IL - Israele 8
CA - Canada 7
ES - Italia 7
ID - Indonesia 7
AT - Austria 6
CO - Colombia 6
AL - Albania 5
IQ - Iraq 5
SA - Arabia Saudita 5
UA - Ucraina 5
ZA - Sudafrica 5
PE - Perù 4
UZ - Uzbekistan 4
JO - Giordania 3
PK - Pakistan 3
PL - Polonia 3
TR - Turchia 3
VE - Venezuela 3
CL - Cile 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KE - Kenya 2
MA - Marocco 2
PA - Panama 2
RU - Federazione Russa 2
SN - Senegal 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
EG - Egitto 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
SE - Svezia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.556
Città #
Santa Clara 530
Singapore 327
Hefei 125
Hong Kong 109
Lauterbourg 59
San Jose 55
Seoul 54
Ho Chi Minh City 44
Ashburn 38
Beijing 26
Hanoi 26
Los Angeles 25
Buffalo 16
Tokyo 15
São Paulo 11
Da Nang 10
New York 8
Minamishinagawa 7
Frankfurt am Main 6
Helsinki 6
Nuremberg 6
Can Tho 5
Haiphong 5
Hải Dương 5
Chennai 4
Dallas 4
Düsseldorf 4
Guayaquil 4
Munich 4
Quito 4
Santo André 4
Tashkent 4
Turku 4
Amman 3
Baghdad 3
Bengaluru 3
Betim 3
Biên Hòa 3
Dhaka 3
Governador Valadares 3
Johannesburg 3
Manaus 3
Orem 3
Porto Alegre 3
Riyadh 3
Salvador 3
Alexandria 2
Araucária 2
Athens 2
Bauru 2
Belo Horizonte 2
Braço do Norte 2
Brooklyn 2
Bình An 2
Bắc Giang 2
Calcinelli 2
Campinas 2
Caracas 2
Caruaru 2
Casablanca 2
Curitiba 2
Dakar 2
Denver 2
El Paso 2
Elk Grove Village 2
Foz do Iguaçu 2
Guarujá 2
Ha Long 2
Hangzhou 2
Hortolândia 2
Huế 2
João Pessoa 2
Juiz de Fora 2
Lima 2
London 2
Louisville 2
Makassar 2
Mexico City 2
Montreal 2
Mumbai 2
Nairobi 2
Naples 2
New Delhi 2
Newark 2
Oklahoma City 2
Panama City 2
Paris 2
Quận Bốn 2
Quận Phú Nhuận 2
Rio de Janeiro 2
Rome 2
Shanghai 2
Shenzhen 2
Springfield 2
Tirana 2
Vienna 2
Vĩnh Yên 2
Warsaw 2
Windsor 2
Ahmedabad 1
Totale 1.700
Nome #
BRAIN DISTRIBUTION AND BINDING OF [C-11]CARIPRAZINE: IN VIVO PET STUDIES IN NON-HUMAN PRIMATES AND WHOLE HEMISPHERE POSTMORTEM AUTORADIOGRAPHIC STUDIES IN HUMAN BRAIN SLICES 93
[F-18]Flumazenil binding to central benzodiazepine receptor studies by PET - Quantitative analysis and comparisons with [C-11]flumazenil 87
Imaging the norepinephrine transporter with positron emission tomography: initial human studies with (S,S)-[(18)F]FMeNER-D (2). 73
Quantitative analysis of [(11)C]AZ10419369 binding to 5-HT(1B) receptors in human brain 71
Supratentorial and Infratentorial Damage in Spinocerebellar Ataxia 2: A Diffusion-Weighted MRI Study 68
Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease. 66
In vivo assessment of changes in serotonin release in the non-human primate brain using PET and [11C]AZ10419369 65
Imaging of the Striatal and Extrastriatal Dopamine Transporter with (18)F-LBT-999: Quantification Biodistribution and Radiation Dosimetry in Nonhuman Primates 53
Kinetic analysis and quantification of the dopamine transporter in the non-human primate brain with [11C]PE2I and [18F]FE-PE2I 52
EANM procedure guidelines for brain neurotransmission SPECT using I-123-labelled dopamine transporter ligands, version 2 49
EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2 48
Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [(18)F]FEDAA1106: a human whole-body PET study 47
Confirmation of fenfluramine effect on 5-HT1B binding of [11C]AZ10419369 using an equilibrium approach 46
Kinetic Analysis and Quantification of the Dopamine Transporter in the Nonhuman Primate Brain with (11)C-PE2I and (18)F-FE-PE2I 45
Age and disease related changes in the translocator protein (TSPO) system in the human brain: Positron emission tomography measurements with [(11)C]vinpocetine 42
Brain Distribution and Binding of 11C-Cariprazine: In Vivo PET Studies in Non-Human Primates and Whole Hemisphere Postmortem Autoradiographic Studies in Human Brain Slices 42
Regional Cerebral Glucose Metabolism After Pridopidine (ACR16) Treatment in Patients With Huntington Disease 42
Dopaminergic Neuronal Imaging in Genetic Parkinson's Disease: Insights into Pathogenesis 41
EANM procedure guidelines for brain tumor imaging using labelled amino acid analogues. 40
Synthesis and evaluation of [(18)F]fluororasagiline a novel PET radioligand for MAO-B 40
Amphetamine decreases binding of the novel alpha2C-adrenoreceptor radioligand [11C]ORM-13070 in monkey brain 39
SPECT imaging of GABA(A)/benzodiazepine receptors and cerebral perfusion in mild cognitive impairment 39
D-Amphetamine decreases [(11)C]AZ10419369 receptor binding in the monkey brain 39
Quantitative measurement of [(11)C]ORM-13070 receptor binding in the monkey brain using a bolus-infusion protocol 39
Extrastriatal Dopamine D(2) Receptor Binding in Huntington's Disease 37
Fenfluramine-Induced Serotonin Release Decreases [C-11]AZ10419369 Binding to 5-HT1B-Receptors in the Primate Brain 36
Mapping of the norepinephrine transporter in the human brain using PET with (S,S)-[F-18]FMeNER-D-2 36
Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson s disease 35
Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 35
Cerebellar and Pyramidal Dysfunctions, Palpebral Ptosis and Weakness As Presenting Symptoms of PARK-2 35
Disturbi del movimento 35
HOW MUCH 18FDG IS NEEDED TO SCAN A GIVEN NUMBER OF ONCOLOGIC PATIENTS WITH PET/CT? 35
Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET 35
Tylor type focal cortical dysplasia is the epilepsy always resistant to medical treatment? 34
Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17. 34
Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT 34
Imaging of dopaminergic dysfunction with [I-123]FP-CIT SPECT in early-onset parkin disease 34
The incremental value of nuclear medicine for patient management and care 33
Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks. 32
Parkinsonism and essential tremor in a family with pseudo-dominant inheritance of PARK2: an FP-CIT SPECT study. 31
EANM procedure guideline for brain perfusion SPECT using Tc-99m-labelled radiopharmaceuticals, version 2 31
The impact of reconstruction method on the quantification of DaTSCAN images 31
PET studies in cynomolgous monkeys and whole hemisphere post mortem autoradiographic studies in human brain slices with the dopamine D2/D3 receptor ligand 11C-cariprazine 31
Metodiche di Tomografia ad emissione: SPECT e PET 30
Molecular Imaging of the Dopamine Transporter 29
Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [I-123]FP-CIT 29
PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism 29
SPECT study of GABAA/BZD receptors and cerebral blood flow in mild cognitive imparment (MCI) 29
Contribution of scatter and attenuation compensation to SPECT images of nonuniformly distributed brain activities 29
In Vitro Autoradiography and In Vivo Evaluation in Cynomolgus Monkey of [F-18]FE-PE2I, a New Dopamine Transporter PET Radioligand 28
Synthesis of three F-18 labeled analogues of 1-deprenyl for PET Studies of monoamine oxidase B 28
Comparative evaluations of norepinephrine transporter radioligands with reference tissue models in rhesus monkeys: (S,S)-[F-18]FMeNER-D-2 and (S,S)-[C-11]MeNER 28
Neuroimaging follow-up in a case of Rasmussen's encephalitis with dyskinesias 28
Changes in Cortical Dopamine D1 Receptor Binding Associated with Cognitive Training 28
Nigrostriatal involvement in ataxia with oculomotor apraxia type 1 27
Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2 27
EANM procedure guidelines for PET brain imaging using [F-18]FDG, version 2 27
Combined MRI and PET-18FDG study in patients with primary progressive (PP) and relapsing remitting (RR) multiple sclerosis (MS) 27
Quantification of serotonin transporter availability with [11C]MADAM - A comparison between the ECAT HRRT and HR systems 26
Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT. 26
Saturated norepinephrine transporter occupancy by atomoxetine relevant to clinical doses: a rhesus monkey study with (S,S)-[F-18]FMeNER-D-2 26
PET Studies of D2-Receptor Binding in Striatal and Extrastriatal Brain Regions: Biochemical Support In Vivo for Separate Dopaminergic Systems in Humans 26
Reduced striatal [123 I]FP-CIT binding in SCA2 patients without parkinsonism. 25
Biodistribution and radiation dosimetry of the norepinephrine transporter radioligand (S,S)-[F-18]FMeNER-D-2: a human whole-body PET study 25
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease. 25
Quantification of [18F]LBT-999 binding to the dopamine transporter in the rhesus monkey brain with the HRRT system 23
Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: the incremental value of nuclear medicine for patient management and care 21
Totale 2.556
Categoria #
all - tutte 7.201
article - articoli 6.660
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 167
Totale 14.028


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20243 0 0 0 0 0 0 0 0 1 0 2 0
2024/20251.281 4 5 108 42 470 62 21 5 26 108 214 216
2025/20261.272 63 139 143 231 237 54 184 61 61 60 39 0
Totale 2.556